Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ankrin Therapeutics ApS
APS
Bankrupt
Advertising protection
CVR 39788705
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
4 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Ankrin Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-4M
2019
-2M
2020
-2M
2021
-1M
2022
0M
2023
EBITDA
DKK millions
0M
-2M
-3M
-5M
-6M
-5M
2019
-4M
+20%
2020
-5M
-25%
2021
-3M
+40%
2022
-2M
+33%
2023
Income statement
DKK thousands
Item
2019
2020
2021
2022
2023
Gross profit
-3.755
-2.067
-2.427
-1.025
-498
Staff expenses
-1.246
-1.827
-2.725
-2.184
-1.594
EBITDA
-5.002
-3.894
-5.153
-3.209
-2.092
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-5.002
-3.894
-5.153
-3.209
-2.092
Net financials
-357
-448
-390
-294
-594
Profit before tax
-5.359
-4.342
-5.543
-3.503
-2.686
Tax
-966
-857
-1.049
-771
-351
Net profit
-4.393
-3.485
-4.493
-2.733
-2.334
Balance sheet
DKK thousands
Item
2019
2020
2021
2022
2023
Total assets
4.425
10.714
6.579
3.656
1.614
Equity
-4.378
2.781
-1.712
-4.445
-6.779
Long-term debt
7.877
6.965
7.300
7.563
8.108
Short-term debt
926
968
991
538
286
Total debt
8.803
7.933
8.291
8.101
8.394
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-209215200.0%
This company
2019
2023
Equity ratio
-419.9%
This company
38.2%
Market median
-1199% vs market
2019
2023
Return on equity
-233445800.0%
This company
18.4%
Market median
-1268727274% vs market
2019
2023
Net profit margin (of gross profit)
-233445800.0%
This company
2019
2023
Asset turnover (of gross profit)
-0.31×
This company
2019
2023
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2018-08-16 – 2019-12-31
View
PDF
More on Ankrin Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
